NatureWise Biotech & Medicals Corporation (TPEX:4732)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
23.60
+0.05 (0.21%)
Jun 6, 2025, 2:59 PM CST
-10.94%
Market Cap 1.17B
Revenue (ttm) 224.32M
Net Income (ttm) 897.00K
Shares Out 49.38M
EPS (ttm) 0.02
PE Ratio 1,299.09
Forward PE n/a
Dividend 0.20 (0.86%)
Ex-Dividend Date Aug 27, 2024
Volume 95,323
Average Volume 100,477
Open 23.30
Previous Close 23.55
Day's Range 22.85 - 23.75
52-Week Range 17.40 - 27.85
Beta 0.65
RSI 61.25
Earnings Date May 13, 2025

About TPEX:4732

NatureWise Biotech & Medicals Corporation engages in the development of therapeutic drugs in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; PPL Taiwan green propolis; and NBM-BMX, an oral softgel capsule to treat cancer. The company was founded in 2000 and is based in Taipei, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 32
Stock Exchange Taipei Exchange
Ticker Symbol 4732
Full Company Profile

Financial Performance

In 2024, TPEX:4732's revenue was 224.32 million, an increase of 40.08% compared to the previous year's 160.14 million. Earnings were 897,000, a decrease of -91.14%.

Financial Statements

News

There is no news available yet.